Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • AtheroNova Inc financial update

    AtheroNova Inc. (OTCBB:AHRO), Irvine, Calif. Business: Cardiovascular Date announced: 2015-02-19 Note: AtheroNova is in default on 2.5% senior secured convertible notes, 6% senior secured convertible notes and 8% senior…

    Published on 2/23/2015
  • Bessemer Venture Partners financial update

    Bessemer Venture Partners, Menlo Park, Calif. Business: Finance Date announced: 2015-02-18 Note: Bessemer Venture Partners raised $1.6 billion for its BVP IX fund, which the firm will invest in several sectors, …

    Published on 2/23/2015
  • BTG pl financial update

    BTG plc (LSE:BTG), London, U.K. Business: Neurology, Cardiovascular, Cancer Date announced: 2015-02-19 Note: BTG is establishing a level I ADR program on the OTC market. Each ADR will represent one ordinary share. …

    Published on 2/23/2015
  • Harvard Apparatus Regenerative Technology Inc financial update

    Harvard Apparatus Regenerative Technology Inc. (NASDAQ:HART), Holliston, Mass. Business: Gene/Cell therapy Date announced: 2015-02-18 Note: Harvard Apparatus raised $472,500 through the sale of 270,000 shares at $1.75 …

    Published on 2/23/2015
  • Idera Pharmaceuticals Inc financial update

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date announced: 2015-02-19 Note: Idera raised $11.3 million through the sale of 3 million shares at $3.75 to cover the …

    Published on 2/23/2015
  • Invitae Corp financial update

    Invitae Corp. (NYSE:NVTA), San Francisco, Calif. Business: Diagnostic Date announced: 2015-02-18 Note: Invitae raised $15.2 million through the sale of 952,500 shares at $16 to cover the overallotment from its Feb.11 …

    Published on 2/23/2015
  • Lineagen financial update

    Lineagen Inc., Salt Lake City, Utah Business: Diagnostic, Genomics Date announced: 2015-02-18 Note: Lineagen raised $12.2 million in a second and final tranche of a series C round, bringing the total amount raised in …

    Published on 2/23/2015
  • RedHill Biopharma Ltd financial update

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL), Ramat-Gan, Israel Business: Drug delivery, Gastrointestinal Date announced: 2015-02-18 Note: Redhill raised 1.9 million through the sale of 150,000 ADSs at $12.50 to …

    Published on 2/23/2015
  • Transition Therapeutics Inc financial update

    Transition Therapeutics Inc. (TSX:TTH; NASDAQ:TTHI), Toronto, Ontario Business: Endocrine/Metabolic, Neurology Date announced: 2015-02-18 Note: Transition raised $3 million through the sale of 461,538 shares at $6.50 to…

    Published on 2/23/2015
  • Ultragenyx Pharmaceutical Inc financial update

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Novato, Calif. Business: Musculoskeletal, Endocrine/Metabolic Date announced: 2015-02-17 Note: Ultragenyx raised $24.3 million through the sale of 450,000 shares at $54 to …

    Published on 2/23/2015
  • VolitionRx Ltd financial update

    VolitionRx Ltd. (NYSE-M:VNRX), Singapore Business: Diagnostic Date announced: 2015-02-17 Note: VolitionRx raised $1.3 million through the sale of 343,383 shares at $3.75 to cover the overallotment from its Feb. 6 follow…

    Published on 2/23/2015
  • WuXi PharmaTech Inc financial update

    WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Business: Supply/Service Date announced: 2015-02-17 Note: WuXi secured a loan facility for up to $165 million from a consortium of banks in Asia led by Citibank. The …

    Published on 2/23/2015
  • Angle pl proposes private placement

    Angle plc (LSE:AGL), Guildford, U.K. Business: Supply/Service, Diagnostic Date announced: 2015-02-16 Type: Private placement To be raised: Up to 1.5 million ($2.3 million) Shares: 2.3 million Price: 65p Shares …

    Published on 2/23/2015
  • Arcadia proposes IPO

    Arcadia Biosciences Inc., Davis, Calif. Business: Agbio/Environmental Date announced: 2015-02-17 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Credit Suisse; JPMorgan; Piper Jaffray …

    Published on 2/23/2015
  • Advanced Accelerator Applications withdraws IPO

    Advanced Accelerator Applications S.A., Saint Genis Pouilly, France Business: Diagnostic, Cancer Date announced: 2015-02-18 Type: IPO Underwriters: Citigroup; Jefferies; Canaccord; JMP Securities Note: Advanced …

    Published on 2/23/2015
  • Achillion completes follow-on

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Date completed: 2015-02-11 Type: Follow-on Raised: $123 million Shares: 12 million Price: $10.25 Shares after offering: 112.2 million …

    Published on 2/16/2015
  • Atara Biotherapeutics completes follow-on

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date completed: 2015-02-12 Type: Follow-on Raised: $65.5 million Shares: 3.6 million Price: $18 Shares after offering: 23.9 million …

    Published on 2/16/2015
  • Bellerophon Therapeutics completes IPO

    Bellerophon Therapeutics Inc. (NASDAQ:BLPH), Hampton, N.J. Business: Cardiovascular Date completed: 2015-02-13 Type: IPO Raised: $60 million Shares: 5 million Price: $12 Shares after offering: 12.9 million Underwriters:…

    Published on 2/16/2015
  • Biocept completes follow-on

    Biocept Inc. (NASDAQ:BIOC), San Diego, Calif. Business: Diagnostic Date completed: 2015-02-09 Type: Follow-on Raised: $10 million Shares: 8 million Price: $1.25 Shares after offering: 12.4 million Underwriters: Aegis …

    Published on 2/16/2015
  • Ceapro completes private placement of convertible debentures and warrants

    Ceapro Inc. (TSX-V:CZO), Edmonton, Alberta Business: Dermatology, Nutraceuticals, Veterinary Date completed: 2015-02-04 Type: Private placement of convertible debentures and warrants Raised: C$310,000 ($242,947) Shares …

    Published on 2/16/2015
  • Cidara Therapeutics completes venture financing

    Cidara Therapeutics Inc., San Diego, Calif. Business: Infectious Date completed: 2015-02-11 Type: Venture financing Raised: $42 million Investors: Institutional investors; new investors; existing investors

    Published on 2/16/2015
  • Delcath completes follow-on

    Delcath Systems Inc. (NASDAQ:DCTH), New York, N.Y. Business: Drug delivery, Cancer Date completed: 2015-02-11 Type: Follow-on Raised: $2.8 million Shares: 2.5 million Price: $1.15 Shares after offering: 12.2 million …

    Published on 2/16/2015
  • DisperSol completes venture financing

    DisperSol Technologies LLC, Georgetown, Texas Business: Drug delivery, Supply/Service Date completed: 2015-02-03 Type: Venture financing Raised: $10 million Investors: Research Corp. Technologies; Acadia Woods Partners;…

    Published on 2/16/2015
  • Enterprise Therapeutics completes venture financing

    Enterprise Therapeutics Ltd., Falmer, U.K. Business: Pulmonary, Inflammation Date completed: 2015-02-12 Type: Venture financing Raised: 1.6 million ($2.4 million) Investor: Epidarex Capital

    Published on 2/16/2015
  • Fluoresentric completes venture financing

    Fluoresentric Inc., Park City, Utah Business: Diagnostic Date completed: 2015-02-09 Type: Venture financing Raised: $1 million Investor: Accredited investors Note: The company raised more than $1 million in the round.

    Published on 2/16/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993